Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
Revenue of Enovis Corporation (ENOV)
Revenue in 2023 (TTM): $1.71 B
According to Enovis Corporation's latest financial reports the company's current revenue (TTM) is $1.71 B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Enovis Corporation
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $1.71 B | $990.78 M | $169.92 M | $-67,128,000 | $-33,261,000 |
| 2022 | $1.56 B | $869.38 M | $225.78 M | $-2,069,000 | $-38,189,000 |
| 2021 | $3.85 B | $1.61 B | $95.03 M | $165.39 M | $98.69 M |
| 2020 | $3.07 B | $1.29 B | $180.05 M | $58.03 M | $64.08 M |
| 2019 | $3.33 B | $1.4 B | $409.22 M | $50.49 M | $18.86 M |
| 2018 | $3.67 B | $1.13 B | $330.29 M | $182.8 M | $140.2 M |
| 2017 | $3.3 B | $1.03 B | $160.41 M | $-11,986,000 | $151.09 M |
| 2016 | $3.65 B | $1.15 B | $349.27 M | $208 M | $128.11 M |
| 2015 | $3.97 B | $1.25 B | $430.59 M | $236.9 M | $167.74 M |
| 2014 | $4.62 B | $1.48 B | $409.55 M | $358.25 M | $392.1 M |
| 2013 | $4.21 B | $1.31 B | $525.65 M | $302.8 M | $178.63 M |
| 2012 | $3.91 B | $1.15 B | $140.01 M | $48.44 M | $-64,402,000 |
| 2011 | $693.39 M | $240.1 M | $25.91 M | $19.99 M | $4.56 M |
| 2010 | $541.99 M | $191.41 M | $34.37 M | $27.69 M | $16.22 M |
| 2009 | $525.02 M | $185.79 M | $54.7 M | $31.25 M | $21.72 M |
| 2008 | $604.85 M | $217.19 M | $16.69 M | $4.87 M | $-571,000 |
| 2007 | $506.31 M | $175.59 M | $140.16 M | $104.03 M | $64.88 M |
| 2006 | $393.6 M | $136.8 M | $32.68 M | $5.36 M | $94 K |
| 2005 | $345.48 M | $123.13 M | $38.99 M | $18.54 M | $12.25 M |
| 2004 | $309.65 M | $111.75 M | $1.73 M | $-5,193,000 | $57.31 M |